Angelman Syndrome

Disease Overview

Angelman Syndrome (AS) is a complex neurodevelopmental genetic disorder characterized by severe intellectual disability, speech impairment, movement and balance problems, and a distinctive happy and excitable demeanor. The condition significantly impacts neurological development and quality of life.

Disease Category

Rare Genetic Neurodevelopmental Disorder

Synonyms

• AS
• Happy Puppet Syndrome (outdated and inappropriate)
• Chromosomal 15q11-q13 Deletion Syndrome

Signs & Symptoms

• Severe developmental delays
• Minimal to no verbal communication
• Frequent smiling and laughing
• Ataxia (impaired motor coordination)
• Epilepsy/seizures
• Microcephaly
• Sleep disturbances
• Hyperactivity
• Intellectual disability
• Motor skill challenges
• Fascination with water
• Strabismus
• Jerky, puppet-like movements
• Difficulty with fine and gross motor skills

Causes

Genetic mutations affecting the UBE3A gene on chromosome 15, specifically: - Maternal chromosome 15q11-q13 deletion - UBE3A gene mutation - Paternal uniparental disomy - Imprinting center defects - Chromosomal rearrangements

Affected Populations

• Prevalence: 1 in 12,000 to 20,000 individuals
• Equal gender distribution
• Occurs across all racial and ethnic groups
• Typically identified in early childhood

Disorders with Similar Symptoms

• Rett Syndrome
• Prader-Willi Syndrome
• Cerebral Palsy
• Autism Spectrum Disorders
• Mowat-Wilson Syndrome

Diagnosis

Diagnostic approaches include: - Comprehensive clinical evaluation - Detailed developmental history - Genetic testing (chromosomal microarray, DNA methylation analysis) - Molecular genetic testing for UBE3A mutations - Electroencephalogram (EEG) to assess seizure patterns - Neurological examination

Standard Therapies

Multidisciplinary management: - Anticonvulsant medications - Physical therapy - Occupational therapy - Speech and communication therapy - Behavioral interventions - Assistive communication technologies - Special education support - Nutritional counseling - Adaptive equipment

Clinical Trials and Studies

Active research areas: - Gene therapy - Targeted molecular interventions - Neurological development studies - Potential pharmaceutical treatments - Registries tracking long-term outcomes

References

• GeneReviews
• National Organization for Rare Disorders (NORD)
• Angelman Syndrome Foundation
• National Institutes of Health (NIH)
• Journal of Medical Genetics

Programs & Resources

• Angelman Syndrome Foundation (ASF)
• Foundation for Angelman Syndrome Therapeutics (FAST)
• Global Angelman Syndrome Registry
• The Arc
• Support groups and online communities

Clinical Trials and Studies

Ongoing research can be found at: - ClinicalTrials.gov - NIH Clinical Trials Registry - International research collaborations

Complete Report

Comprehensive medical and genetic counseling recommended for affected families to understand the condition's complexities and management strategies.